Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Verluma Market Growth From $ Billion In 2026 To $ Billion By 2030 At A CAGR Of %
The historic growth was driven by advancements in nuclear imaging technologies, a rising incidence of colorectal and solid tumors, enhanced access to radiopharmaceuticals, the broadening of oncology diagnostic infrastructure, and a growing clinical adoption of targeted imaging agents.
The expansion observed during the forecast period is largely driven by the increasing need for customized cancer diagnostic solutions, a surge in funding dedicated to nuclear medicine centers, the broadening scope of companion diagnostic applications within oncology, the heightened utilization of molecular imaging techniques for cancer staging, and continuous advancements in the development of radiolabeled antibody fragments. Key developments shaping this period encompass the rising preference for specifically targeted radiolabeled diagnostic tools, a greater reliance on imaging agents designed to target carcinoembryonic antigen (CEA), the growing market demand for instruments capable of early cancer detection, the widening range of uses for nuclear medicine imaging, and a stronger emphasis on incorporating precision oncology diagnostics into clinical practice.
Download A Free Sample Report For Comprehensive Market Insights:
#Verluma Market Growth Factors: Which Forces Are Supporting Market Expansion?
The growing occurrence of cancer is anticipated to drive expansion in the verluma market moving forward. Cancer encompasses a range of diseases marked by the unregulated proliferation and dissemination of abnormal cells, which can infiltrate adjacent tissues and possibly extend to other areas of the body via the blood and lymphatic systems. This increase in cancer cases stems from aging populations, shifts in lifestyle habits, and the worldwide spread of risk factors. Verluma is a therapeutic device leveraging cutting-edge technology, such as electromagnetic fields or alternative non-invasive approaches, to aid in cancer treatment by preventing cancer cell proliferation, fostering recovery, and enhancing the effectiveness of other therapies. For example, the American Cancer Society, a non-profit cancer advocacy organization based in the U.S., reported in 2024 that around 313,510 fresh breast cancer diagnoses occurred, marking a rise from the 300,590 instances recorded in 2023. Consequently, the rising prevalence of cancer is fueling growth in the verluma market.
The escalating demand for diagnostic imaging procedures is projected to accelerate growth in the verluma market going forward. Diagnostic imaging procedures include diverse medical methods employed to generate visual depictions of the body’s interior for clinical evaluation and medical intervention. The need for these procedures is expanding due to the higher prevalence of chronic illnesses, a stronger emphasis on early diagnosis and preventative healthcare, and improved healthcare accessibility. Verluma enhances diagnostic imaging processes by refining image quality via sophisticated algorithms, facilitating more precise identification and assessment of medical issues, and boosting patient outcomes. As an illustration, the National Health Service, a UK government department, noted in November 2023 that England conducted 45.0 million imaging tests in the year ending March 2023, representing a 2.2% rise from 44.0 million in 2022. Hence, the growing demand for diagnostic imaging procedures is propelling the verluma market forward.
The increase in healthcare spending is expected to drive growth in the verluma market moving forward. Healthcare spending encompasses all financial resources allocated to health services, covering medical treatments, hospital care, pharmaceuticals, health infrastructure, and preventive measures. This rise stems from factors like an aging populace, a higher incidence of chronic conditions, progress in medical technologies, and elevated need for health services. Healthcare expenditure benefits Verluma by boosting demand for sophisticated healthcare technologies, especially those enhancing patient results and operational effectiveness, as providers invest in innovative equipment and systems. For instance, the Office for National Statistics, a UK government body, reported in April 2025 that provisional estimates place UK healthcare spending at £317 billion in 2024, showing a 6.5% nominal increase and a 2.4% real-terms rise from 2023. Total long-term care outlays went up by 3.1% in real terms in 2023, driven mainly by heightened government funding. Therefore, the surge in healthcare expenditure is advancing the growth of the verluma market.
Verluma Market Segmentation: How Is The Market Structured Across Key Categories?
The verluma market covered in this report is segmented –
1) By Indication: Cancer, Non-Cancer
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies
3) By End User: Adult, Geriatric
Verluma Market Competitive Landscape And Leading Companies
Major companies operating in the verluma market are Boehringer Ingelheim International GmbH
Access The Complete Verluma Market Report:
Verluma Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the verluma market in 2025. The regions covered in the verluma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model